Parkinson's Disease (PD) is a neurodegenerative disease characterized by its hallmark motor symptoms of bradykinesia and tremor. Numerous studies have suggested novel quantification methods of its symptoms. However, there lacks the means to accurately assess improvements in an intraoperative setting during deep brain stimulation (DBS) electrode implantation. This study introduces a methodology to quantify selected PD motor symptoms in such a restrictive environment using a wireless Leap Motion sensor. The result suggests that utilizing the Leap Motion sensor intraoperatively is feasible for quantifying motor parameters for bradykinesia and resting tremor of a PD patient.